Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene

Jones, Siân, Hruban, Ralph H., Kamiyama, Mihoko, Borges, Michael, Zhang, Xiaosong, Parsons, D. Williams, Lin, Jimmy Cheng-Ho, Palmisano, Emily, Brune, Kieran, Jaffee, Elizabeth M., Iacobuzio-Donahue, Christine A., Maitra, Anirban, Parmigiani, Giovanni, Kern, Scott E, Velculescu, Victor E., Kinzler, Kenneth W., Vogelstein, Bert, Eshleman, James R., Goggins, Michael, Klein, Alison P.·2009·Science
DOI 10.1126/science.1171202

Cited by (831)

Items 201–300 of 831

  1. Targeting pancreatic cancer with a G-quadruplex ligand
    Mekala Gunaratnam, Maria de la Fuente, Sonja M. Hampel, Alan K. Todd, Anthony P. Reszka, Andreas G. Schätzlein, Stephen Neidle · 2011 · Bioorganic & Medicinal Chemistry
  2. Clinical and pathologic features of familial pancreatic cancer
    Jeremy L. Humphris, Amber L. Johns, Skye H. Simpson, Mark J. Cowley, Marina Pajic, David Kuang-Fu Chang, Adnan M. Nagrial, Venessa T. Chin, Lorraine A. Chantrill, Mark Pinese et al. · 2014 · Cancer
  3. A Susceptibility Locus on Chromosome 6q Greatly Increases Lung Cancer Risk among Light and Never Smokers
    Christopher Ian Amos, Susan M. Pinney, Yafang Li, Elena Y. Kupert, Juwon Lee, Mariza A. de Andrade, Ping Yang, Ann G. Schwartz, Pam R. Fain, Adi F. Gazdar et al. · 2010 · Cancer Research
  4. Diagnostic Cancer Genome Sequencing and the Contribution of Germline Variants
    Outi Kilpivaara, Lauri A. Aaltonen · 2013 · Science
  5. Secondary Prevention in Hereditary Breast and/or Ovarian Cancer Syndromes Other Than BRCA
    Claudia Piombino, Laura Cortesi, Matteo Lambertini, Kevin Punie, Giovanni Grandi, Angela Toss · 2020 · Journal of Oncology
  6. Genetic susceptibility to pancreatic cancer and its functional characterisation: The PANcreatic Disease ReseArch (PANDoRA) consortium
    Daniele Campa, Cosmeri Rizzato, Gabriele Capurso, Nathalia A. Giese, Niccola Funel, William Greenhalf, Pavel Souček, Maria Gazouli, Raffaele Pezzilli, Claudio Pasquali et al. · 2012 · Digestive and Liver Disease
  7. Pancreatic cancer genomics
    David Kuang-Fu Chang, Sean Michael Grimmond, Andrew Victor Biankin · 2014 · Current Opinion in Genetics & Development
  8. Family history of cancer, Ashkenazi Jewish ancestry, and pancreatic cancer risk
    Hamada, Tsuyoshi, Yuan, Chen, Yurgelun, Matthew B., Perez, Kimberly, Khalaf, Natalia, Morales-Oyarvide, Vicente, Babic, Ana, Nowak, Jonathan A., Rubinson, Douglas A., Giannakis, Marios et al. · 2019 · British Journal of Cancer
  9. Apoptosis and anergy of T cell induced by pancreatic stellate cells-derived galectin-1 in pancreatic cancer
    Dong Tang, Jun Gao, Sen Wang, Zhongxu Yuan, Nianyuan Ye, Yang Chong, Chuanqi Xu, Xuetong Jiang, Bin Li, Wei Yin et al. · 2015 · Tumor Biology
  10. Hacking Pancreatic Cancer: Present and Future of Personalized Medicine
    Alessandro Di Federico, Valentina Tateo, Claudia Parisi, Francesca Formica, Riccardo Carloni, Giorgio Frega, Alessandro Rizzo, Dalia Ricci, Mariacristina Di Marco, Andrea Palloni et al. · 2021 · Pharmaceuticals
  11. PALB2 self-interaction controls homologous recombination
    Rémi Buisson, Jean‐Yves Masson · 2012 · Nucleic Acids Research
  12. Genome-Wide Somatic Copy Number Alterations in Low-Grade PanINs and IPMNs from Individuals with a Family History of Pancreatic Cancer
    Seung‐Mo Hong, Audrey Vincent, Mitsuro Kanda, Julie Leclerc, Noriyuki Omura, Michael W. Borges, Alison P. Klein, Marcia Irene Canto, Ralph H. Hruban, Michael Goggins · 2012 · Clinical Cancer Research
  13. Molecular landscape of prostate cancer: Implications for current clinical trials
    Galina Khemlina, Sadakatsu Ikeda, Razelle Kurzrock · 2015 · Cancer Treatment Reviews
  14. Molecular Characteristics of Pancreatic Ductal Adenocarcinoma
    Niki A. Ottenhof, Roeland F. de Wilde, Anirban Maitra, Ralph H. Hruban, G. Johan A. Offerhaus · 2011 · Pathology Research International
  15. Molecular Pathogenesis of Pancreatic Cancer and Clinical Perspectives
    Dimitrios Matthaios, Paul Zarogoulidis, Ioanna Balgkouranidou, Εkaterini Chatzaki, Stylianos Kakolyris · 2011 · Oncology
  16. Detection of a large rearrangement in PALB2 in Spanish breast cancer families with male breast cancer
    Ana Blanco, Miguel de la Hoya, Judith Balmañà, Teresa Ramón y Cajal, Àlex Teulé, María-Dolores Miramar, Eva Esteban, Mar Infante, Javier J. Benitez, Asunción Torres et al. · 2011 · Breast Cancer Research and Treatment
  17. MRG15-mediated tethering of PALB2 to unperturbed chromatin protects active genes from genotoxic stress
    Jean‐Yves Bleuyard, Marjorie L. Fournier, Ryuichiro Nakato, Anthony M. Couturier, Yuki Katou, Christine Ralf, Svenja Hester, Daniel Dominguez, Daniela Rhodes, Timothy C. Humphrey et al. · 2017 · Proceedings of the National Academy of Sciences
  18. Molecular pathology of pancreatic cancer
    Yuriko Saiki, Akira Horii · 2014 · Pathology International
  19. Palb2 synergizes with Trp53 to suppress mammary tumor formation in a model of inherited breast cancer
    Christian Bowman-Colin, Bing Xia, Samuel F. Bunting, Christiaan N. Klijn, Rinske Drost, Peter Bouwman, Laura Fineman, Xixi Chen, Aedín C. Culhane, Hong Cai et al. · 2013 · Proceedings of the National Academy of Sciences
  20. Genomic Features and Clinical Management of Patients with Hereditary Pancreatic Cancer Syndromes and Familial Pancreatic Cancer
    Akihiro Ohmoto, Shinichi Yachida, Chigusa Morizane · 2019 · International Journal of Molecular Sciences
  21. Genomics of medulloblastoma: from Giemsa-banding to next-generation sequencing in 20 years
    Paul A. Northcott, James T. Rutka, Michael D. Taylor · 2009 · Neurosurgical FOCUS
  22. Familial pancreatic adenocarcinoma
    Petersen, Gloria M. · 2015 · Hematology/Oncology Clinics of North America
  23. What are we learning from the cancer genome?
    Eric A. Collisson, Raymond Jaihyun Cho, Joe W. Gray · 2012 · Nature Reviews Clinical Oncology
  24. Germline mutations in the PALB2 gene are population specific and occur with low frequencies in familial breast cancer
    Heide Hellebrand, Christian Sutter, Ellen Honisch, Eva Groß, Barbara Wappenschmidt, Christian Schem, Helmut Deißler, Nina Caroline Ditsch, Verena Gress, Marion B. Kiechle et al. · 2011 · Human Mutation
  25. Reliable Detection of Somatic Mutations in Fine Needle Aspirates of Pancreatic Cancer With Next-generation Sequencing
    Vicente Valero, Tyler Saunders, Jin Peng He, Matthew John Weiss, John L. Cameron, Avani Satish Dholakia, Aaron Tyler Wild, Eun Ji Shin, Mouen A. Khashab, Anne Marie Lennon et al. · 2015 · Annals of Surgery
  26. The Impact of obesity and diabetes mellitus on pancreatic cancer: Molecular mechanisms and clinical perspectives
    Bao Lam, Sushant Kumar Shrivastava, Anju Shrivastava, Sharmila Shankar, Rakesh K. Srivastava · 2020 · Journal of Cellular and Molecular Medicine
  27. Inactivation of Palb2 gene leads to mesoderm differentiation defect and early embryonic lethality in mice
    Pia Rantakari, Jenni Nikkilä, Heli Jokela, Roxana Ola, Katri Pylkäs, Heidi Lagerbohm, Kirsi Sainio, Matti H. POUTANEN, Robert Winqvist · 2010 · Human Molecular Genetics
  28. Screening and early detection of pancreatic cancer in high risk population
    Ming‐Chu Chang · 2014 · World Journal of Gastroenterology
  29. Molecular Mechanisms Underlying the Role of MicroRNAs in the Chemoresistance of Pancreatic Cancer
    Ingrid Garajová, Tessa Y. S. Le Large, Adam Enver Frampton, Christian D. Rolfo, Johannes Voortman, Elisa Giovannetti · 2014 · BioMed Research International
  30. Candidate DNA repair susceptibility genes identified by exome sequencing in high-risk pancreatic cancer
    Alyssa L. Smith, Najmeh Alirezaie, Ashton Anthony Connor, Michelle Chan‐Seng‐Yue, Robert C. Grant, Iris Selander, Claire Bascuñana, Ayelet Borgida, Anita Hall, Thomas Whelan et al. · 2015 · Cancer Letters
  31. PALB2 mutations in German and Russian patients with bilateral breast cancer
    Natalia Viktorovna Bogdanova, Анна Петровна Соколенко, Aglaya G. Iyevleva, Светлана Николаевна Алексахина, Magda A Blaut, Michael Bremer, Hans Christiansen, Margret Rave‐Fränk, Thilo Dörk, Евгений Наумович Имянитов · 2010 · Breast Cancer Research and Treatment
  32. Genomic instability in pancreatic adenocarcinoma: a new step towards precision medicine and novel therapeutic approaches
    İbrahim Halil Şahin, Maeve Aine Lowery, Zsofia Kinga Stadler, Erin E. Salo‐Mullen, Christine A. Iacobuzio–Donahue, David Paul Kelsen, Eileen Mary O'Reilly · 2016 · Expert Review of Gastroenterology & Hepatology
  33. Identification of candidate cancer predisposing variants by performing whole-exome sequencing on index patients from BRCA1 and BRCA2-negative breast cancer families
    Rajendra Bahadur Shahi, Sylvia De Brakeleer, Ben Caljon, Ingrid Pauwels, M Bonduelle, Sofie Joris, Christel Fontaine, Marian Vanhoeij, Sonia Van Dooren, Erik Teugels et al. · 2019 · BMC Cancer
  34. PALB2 analysis in BRCA2-like families
    Muriel A. Adank, Saskia E. van Mil, J. J. P. Gille, Quinten Waisfisz, Hanne E.J. Meijers-Heijboer · 2010 · Breast Cancer Research and Treatment
  35. Effective screening for early diagnosis of pancreatic cancer
    Keiji Hanada, Akihito Okazaki, Naomichi Hirano, Yoshihiro Izumi, Tomoyuki Minami, Juri Ikemoto, Kozue Kanemitsu, Fumiaki Hino · 2015 · Best Practice & Research Clinical Gastroenterology
  36. Advances in membrane proteomics and cancer biomarker discovery: Current status and future perspective
    Hem Dutt Shukla, Paulius Vaitiekunas, Robert J. Cotter · 2012 · PROTEOMICS
  37. Analysis of PALB2 Gene in BRCA1/BRCA2 Negative Spanish Hereditary Breast/Ovarian Cancer Families with Pancreatic Cancer Cases
    Ana Blanco, Miguel de la Hoya, Ana Osório, Orland Dı́ez, María Dolores Miramar, Mar Infante, Cristina Martínez-Bouzas, Asunción Torres, Adriana Lasa, Gemma Llort et al. · 2013 · PLoS ONE
  38. Genome‐wide analysis reveals a role for BRCA1 and PALB2 in transcriptional co‐activation
    Andrea Gardini, David Baillat, Matteo Cesaroni, Ramin Shiekhattar · 2014 · The EMBO Journal
  39. The PALB2 Gene Is a Strong Candidate for Clinical Testing in BRCA1 - and BRCA2 -Negative Hereditary Breast Cancer
    Markéta Janatová, Zdeněk Kleibl, Jana Stribrna, Ales Panczak, Kamila Veselá, Martina Zimovjanová, Petra Kleiblová, Pavel Dundr, Jana Soukupová, Petr Pohlreich · 2013 · Cancer Epidemiology Biomarkers & Prevention
  40. Overview of the genetic basis toward early detection of breast cancer
    Sumadee De Silva, Kamani Hemamala Tennekoon, Eric Hamilton Karunanayake · 2019 · Breast Cancer Targets and Therapy
  41. Genomics of adult and pediatric solid tumors.
    Zahraa Rahal, Farah Abdulhai, Humam N. Kadara, Raya Hamad Saab · 2018 · Europe PMC (PubMed Central)
  42. A Finnish founder mutation in RAD51D: analysis in breast, ovarian, prostate, and colorectal cancer: Table 1
    Liisa M. Pelttari, Johanna I. Kiiski, Riikka Nurminen, Anne H. Kallioniemi, Johanna Schleutker, Alexandra E. Gylfe, Lauri A. Aaltonen, Arto Leminen, Päivi Heikkilä, CARL P. BLOMQVIST et al. · 2012 · Journal of Medical Genetics
  43. Risk Factors and Therapeutic Targets in Pancreatic Cancer
    Sonja M. Wörmann, Hana Algül · 2013 · Frontiers in Oncology
  44. A global functional analysis of missense mutations reveals two major hotspots in the PALB2 tumor suppressor
    Amélie Rodrigue, Guillaume Margaillan, Thiago T. Gomes, Yan Coulombe, Gemma Montalban, Simone da Costa e Silva Carvalho, Larissa Milano, Mandy Ducy, Giuliana De Gregoriis, Graham Dellaire et al. · 2019 · Nucleic Acids Research
  45. Germline copy number variation in theYTHDC2gene: does it have a role in finding a novel potential molecular target involved in pancreatic adenocarcinoma susceptibility?
    Daniele Fanale, Juan Iovanna, Ezequiel Luis Calvo, P. Berthézène, Pascal Belleau, Jean Charles Dagorn, Giuseppe Bronte, Giuseppe Cicero, Viviana Bazan, Christian Diego Rolfo et al. · 2014 · Expert Opinion on Therapeutic Targets
  46. Germline Variants and Risk for Pancreatic Cancer
    Wei Zhan, Celeste A. Shelton, Phil J. Greer, Randall E. Brand, David Clement Whitcomb · 2018 · Pancreas
  47. Familial Pancreatic Cancer: Current Perspectives
    Joan Llach, Sabela Carballal, Leticia Moreira · 2020 · Cancer Management and Research
  48. PanGen-Fam: Spanish registry of hereditary pancreatic cancer
    Evelina Mocci, Carmen Guillén‐Ponce, Julie Earl, Mirari Márquez, Jesús Solera, Maria-Teresa Salazar-Lopez, C. Calcedo-Arnáiz, Enrique Vázquez-Sequeiros, José Montáns, María Muñoz Beltrán et al. · 2015 · European Journal of Cancer
  49. Multiple small “imaging” branch-duct type intraductal papillary mucinous neoplasms (IPMNs) in familial pancreatic cancer: indicator for concomitant high grade pancreatic intraepithelial neoplasia?
    Detlef Klaus Bartsch, K. Dietzel, Mathias Bargello, E. Matthaei, Guenter Kloeppel, Iréne Esposito, Johannes T. Heverhagen, Thomas Mathias Gress, E. P. Slater, P. Langer · 2012 · Familial Cancer
  50. The complexity of pancreatic ductal cancers and multidimensional strategies for therapeutic targeting
    Scott E. Kern, Chanjuan Shi, Ralph H. Hruban · 2010 · The Journal of Pathology
  51. Inherited mutations in DNA repair genes and cancer risk
    Nuria Romero-Laorden, Elena Castro · 2017 · Current Problems in Cancer
  52. Genetic Alterations of Periampullary and Pancreatic Ductal Adenocarcinoma: An Overview
    Nilabja Sikdar, Gourab Saha, Ashmita Dutta, Shibajyoti Ghosh, Shailesh Vinayak Shrikhande, Sudeep Banerjee · 2018 · Current Genomics
  53. Hereditary breast cancer syndromes and genetic testing
    Thereasa A. Rich, Ashley Woodson, Jennifer Keating Litton, Banu K Arun · 2014 · Journal of Surgical Oncology
  54. Prevalence of PALB2 mutations in Australasian multiple-case breast cancer families
    Zhi Ling Teo, Daniel Jonathan Park, Elena Provenzano, Catherine Chatfield, Fabrice Odefrey, Tú Nguyen‐Dumont, kConFab, James G. Dowty, John Llewelyn Hopper, Ingrid Winship et al. · 2013 · Breast Cancer Research
  55. Exome-Wide Association Study of Pancreatic Cancer Risk
    Robert C. Grant, Robert Edward Denroche, Ayelet Borgida, Carl Virtanen, Natalie Cook, Alyssa L. Smith, Ashton Anthony Connor, Julie M. Wilson, Gloria Peterson, Nicholas Jason Roberts et al. · 2017 · Gastroenterology
  56. Adenocarcinoma of the pancreas
    Ralph H. Hruban, David S. Klimstra · 2014 · Seminars in Diagnostic Pathology
  57. Next-Generation Sequencing in Pancreatic Cancer
    Gong-Qing Shen, Essa M. Aleassa, Richard Matthew Walsh, Gareth J Morris‐Stiff · 2019 · Pancreas
  58. Detection of Early-Stage Pancreatic Adenocarcinoma
    David V. Gold, Michael Goggins, David E. Modrak, Guy Newsome, Mengling Liu, Chanjuan Shi, Ralph H. Hruban, David M. Goldenberg · 2010 · Cancer Epidemiology Biomarkers & Prevention
  59. The role of TGF-β in the tumor microenvironment of pancreatic cancer
    Qiang Luo, Ziquan Hu, Hongcheng Zhao, Yanmei Fan, Xiancong Tu, Yueqing Wang, Xiaowen Liu · 2022 · Genes & Diseases
  60. Genome‐wide germline analyses on cancer susceptibility and GeMDBJ database: Gastric cancer as an example
    T. Yoshida, H. Ono, A. Kuchiba, N. Saeki, H. Sakamoto · 2010 · Cancer Science
  61. PALB2 and breast cancer: ready for clinical translation!
    Melissa C. Southey, Teo, Ingrid Winship · 2013 · The Application of Clinical Genetics
  62. Drug therapy for hereditary cancers
    Евгений Наумович Имянитов, Vladimir Mikhailovich Moiseyenko · 2011 · Hereditary Cancer in Clinical Practice
  63. Analysis of Induced Pluripotent Stem Cells from a BRCA1 Mutant Family
    Abigail A. Soyombo, Yipin Wu, Lauren Kolski, Jonathan J. Rios, Dinesh Rakheja, Alice P. Chen, James Kehler, Heather Hampel, Alanna J. Coughran, Theodora Suzanne Ross · 2013 · Stem Cell Reports
  64. Homologous recombination repair-dependent cytotoxicity of the benzotriazine di-N-oxide CEN-209: Comparison with other hypoxia-activated prodrugs
    Francis W. Hunter, Jingli Wang, Rita Patel, Huai‐Ling Hsu, Anthony J. Hickey, Michael P. Hay, William Robert Wilson · 2011 · Biochemical Pharmacology
  65. Loss of p53 partially rescues embryonic development of Palb2 knockout mice but does not foster haploinsufficiency of Palb2 in tumour suppression
    Peter Bouwman, Rinske Drost, Christiaan N. Klijn, Mark Pieterse, Hanneke M.L. van der Gulden, Ji‐Ying Song, Károly Szuhai, Jos Jonkers · 2011 · The Journal of Pathology
  66. Targeting DNA Damage Response and Immune Checkpoint for Anticancer Therapy
    Huang, Jau-Ling, Chang, Yu-Tzu, Hong, Zhen-Yang, Lin, Chang-Shen · 2022 · International Journal of Molecular Sciences
  67. Risk of Pancreatic Cancer in the Long-Term Prospective Follow-Up of Familial Pancreatic Cancer Kindreds
    Nancy R. Porter, Daniel A. Laheru, Bryan M. Lau, Jin Peng He, Lei Zheng, Amol Kumar Narang, Nicholas Jason Roberts, Marcia Irene Canto, Anne Marie Lennon, Michael Goggins et al. · 2022 · JNCI Journal of the National Cancer Institute
  68. Hereditary breast cancer: beyond BRCA genetic analysis; PALB2 emerges
    Νικολέτα Πουμπουρίδου, Christos Κroupis · 2012 · Clinical Chemistry and Laboratory Medicine (CCLM)
  69. Routine testing for PALB2 mutations in familial pancreatic cancer families and breast cancer families with pancreatic cancer is not indicated
    Femme Harinck, Irma Kluijt, Saskia E. van Mil, Quinten Waisfisz, Theo A.M. van Os, Cora M. Aalfs, Anja Wagner, Maran J.W. Olderode-Berends, Rolf H. Sijmons, Ernst Johan Kuipers et al. · 2011 · European Journal of Human Genetics
  70. Inherited pancreatic cancer
    Fei Chen, Nicholas Jason Roberts, Alison P. Klein · 2017 · Chinese Clinical Oncology
  71. Identification of novel hereditary cancer genes by whole exome sequencing
    Анна Петровна Соколенко, Evgeny N. Suspitsin, Ekatherina Sh. Kuligina, Бизин Илья Валерьевич, Dmitrij Frishman, Евгений Наумович Имянитов · 2015 · Cancer Letters
  72. Clinical cancer genomics: how soon is now?
    Barry S. Taylor, Marc Ladanyi · 2010 · The Journal of Pathology
  73. Prevalence of PALB2 mutations in Australian familial breast cancer cases and controls
    LifePool Investigators, Ella R. Thompson, Kylie L. Gorringe, Simone M. Rowley, Michelle W. Wong‐Brown, Simone McInerny, Na Li, Alison H. Trainer, Lisa Devereux, Maria Doyle et al. · 2015 · Breast Cancer Research
  74. Targeted resequencing of the microRNAome and 3′UTRome reveals functional germline DNA variants with altered prevalence in epithelial ovarian cancer
    X Chen, Trupti Paranjape, Carlos E. Stahlhut, Terri Patricia McVeigh, Florence K. Keane, Sunitha V. Nallur, Nicola Miller, Michael Joseph Kerin, Yanxiang Deng, Xinwei Yao et al. · 2014 · Oncogene
  75. Squamous Cell Carcinomas of the Head and Neck in Fanconi Anemia: Risk, Prevention, Therapy, and the Need for Guidelines
    Kathrin Scheckenbach, Martin Wagenmann, Marcel Freund, J. Schipper, Helmut Hanenberg · 2012 · Klinische Pädiatrie
  76. High Prevalence of Hereditary Cancer Syndromes and Outcomes in Adults with Early-Onset Pancreatic Cancer
    Bannon, Sarah A., Montiel, Maria F., Goldstein, Jennifer B., Dong, Wenli, Mork, Maureen E., Borras, Ester, Hasanov, Merve, Varadhachary, Gauri R., Maitra, Anirban, Katz, Matthew H. et al. · 2018 · Cancer Prevention Research
  77. Risk Factors of Familial Pancreatic Cancer in Japan
    Hiroyuki Matsubayashi, Atsuyuki Maeda, Hideyuki Kanemoto, Katsuhiko Uesaka, Kentaro Yamazaki, Shuichi Hironaka, Yuji Miyagi, Hisatomo Ikehara, Hiroyuki Ono, Alison P. Klein et al. · 2011 · Pancreas
  78. The genetic heterogeneity of colorectal cancer predisposition - guidelines for gene discovery
    Marc‐Manuel Hahn, Richarda M. de Voer, Nicoline Hoogerbrugge, Marjolijn J. L. Ligtenberg, Roland P. Kuiper, Ad Geurts van Kessel · 2016 · Cellular Oncology
  79. Comprehensive Analysis of Cancer-Proteogenome to Identify Biomarkers for the Early Diagnosis and Prognosis of Cancer
    Hem Dutt Shukla · 2017 · Proteomes
  80. Response to olaparib in a PALB2 germline mutated prostate cancer and genetic events associated with resistance
    Peter Horak, Joachim Weischenfeldt, Gunhild v. Amsberg, Burkhard Beyer, Andreas Schütte, Sebastian Uhrig, Laura Gieldon, Barbara Klink, Lars Feuerbach, Daniel Hübschmann et al. · 2019 · Molecular Case Studies
  81. Next-generation sequencing applied to molecular diagnostics
    Rachael Natrajan, Jorge Sergio Reis-Filho · 2011 · Expert Review of Molecular Diagnostics
  82. Poly(ADP-Ribose) Polymerase Inhibitors in Pancreatic Cancer: A New Treatment Paradigms and Future Implications
    Medhavi Gupta, Renuka V. Iyer, Christos K Fountzilas · 2019 · Cancers
  83. The genetics of ductal adenocarcinoma of the pancreas in the year 2020: dramatic progress, but far to go
    Elizabeth D. Thompson, Nicholas Jason Roberts, Laura DeLong Wood, James R. Eshleman, Michael Goggins, Scott E. Kern, Alison P. Klein, Ralph H. Hruban · 2020 · Modern Pathology
  84. GENOME-WIDE ANALYSIS OF TRIPLE-NEGATIVE PHENOTYPE BREAST TUMORS
    М.K. Ibragimova, M.M. Tsyganov, N.V. Litvyakov · 2022 · Cardiometry
  85. ACCOMPANYING TRANSCRANIAL MAGNETOTHERAPY IN COMBINATION TREATMENT OF HIGH-GRADE GLIAL BRAIN TUMORS
    I.A. Popov, A.I. Shikhlyarova, E.M. Frantsiyants, I.V. Kaplieva · 2022 · Cardiometry
  86. GD2-SPECIFIC CAR-T CELLS CO-EXPRESSING THE IL15 MEMBRANE FORM EFFECTIVELY LYSE GD2-POSITIVE CELL TARGETS
    M.D. Mollaev, П. Н. Вихрева, А. В. Кибардин, V.E. Mayorova, Roman V. Kholodenko, Elena A. Kulakovskaya, Dmitry Pershin, M.A. Maschan, S.S. Larin · 2022 · Cardiometry
  87. STUDY OF BIOLOGICAL ACTIVITY OF DOXORUBICIN CONJUGATE WITH NACETYL-D-GALACTOSAMINE HYDRASONIC LINKER
    Anna S. Pestretsova, D.V. Kozina, D.V. Sokolova, V.S. Pokrovsky, E.K. Beloglazkina · 2022 · Cardiometry
  88. INFLUENCE OF HYPOTHYROIDISM ON THE HYPOTHALAMIC-PITUITARYGONADAL AXIS IN RATS WITH GUERIN'S TUMOR
    E.M. Frantsiyants, V.A. Bandovkina, Irina Viktorovna Kaplieva, Ekaterina Igorevna Surikova, Irina Valer'evna Neskubina, L.K. Trepitaki, A.I. Shikhlyarova, Irina Aleksandrovna Goroshinskaya, G.V. Zhukova, Ludmila Anatolievna Nemashkalova et al. · 2022 · Cardiometry
  89. Quality control of homologous recombination
    Ting Liu, Jun Huang · 2014 · Cellular and Molecular Life Sciences
  90. Gene discovery in familial cancer syndromes by exome sequencing: prospects for the elucidation of familial colorectal cancer type X
    Chee‐Seng Ku, D.N. Cooper, Mengchu Wu, Dimitrios H Roukos, Yudi Pawitan Y, Richie Soong, Barry J. Iacopetta · 2012 · Modern Pathology
  91. Exploring the roles of PALB2 at the crossroads of DNA repair and cancer
    Joris Pauty, Amélie Rodrigue, Anthony M. Couturier, Rémi Buisson, Jean‐Yves Masson · 2014 · Biochemical Journal
  92. Insights into Genetic Susceptibility to Melanoma by Gene Panel Testing: Potential Pathogenic Variants in ACD, ATM, BAP1, and POT1
    Lorenza Pastorino, Virginia Andreotti, Bruna Dalmasso, Irene Vanni, Giulia Ciccarese, Mario Mandalà, Giuseppe Spadola, Maria Antonietta Pizzichetta, Giovanni Ponti, Maria Grazia Tibiletti et al. · 2020 · Cancers
  93. The Use of Glucagon-like Peptide-1 Receptor Agonists in Patients with Type 2 Diabetes Mellitus Does Not Increase the Risk of Pancreatic Cancer: A U.S.-Based Cohort Study
    Mark Ayoub, Carol Faris, Tajana Juranovic, Harleen Kaur Chela, Ebubekir S. Daglilar · 2024 · Cancers
  94. The genetics of epilepsy—The past, the present and future
    Mark I. Rees · 2010 · Seizure
  95. Novel germline PALB2 truncating mutations in African American breast cancer patients
    Yonglan Zheng, Jing Zhang, Qun Niu, Dezheng Huo, Olufunmilayo Ibironke Olopade · 2011 · Cancer
  96. PALB2 germline mutations in familial breast cancer cases with personal and family history of pancreatic cancer
    Paolo Peterlongo, Irene Catucci, Graziella Pasquini, Paolo Verderio, Bernard Peissel, Monica Barile, Liliana Varesco, Mirko Riboni, Stefano Fortuzzi, Siranoush Manoukian et al. · 2010 · Breast Cancer Research and Treatment
  97. Disease-specific prospective family study cohorts enriched for familial risk
    John Llewelyn Hopper · 2011 · Epidemiologic Perspectives & Innovations
  98. Molecular Biology of Pancreatic Ductal Adenocarcinoma Progression
    Andrew D. Rhim, Ben Z. Stanger · 2010 · Progress in molecular biology and translational science
  99. Epidemiology and Inherited Predisposition for Sporadic Pancreatic Adenocarcinoma
    Rachael Z. Stolzenberg‐Solomon, Laufey Thora Amundadottir · 2015 · Hematology/Oncology Clinics of North America
  100. Exome sequencing identifies nonsegregating nonsense ATM and PALB2variants in familial pancreatic cancer
    Robert C. Grant, Wigdan Al-Sukhni, Ayelet Borgida, Spring Holter, Zaheer S. Kanji, Treasa A. McPherson, Emily R. Whelan, Stefano Serra, Quang M. Trinh, Vanya D. Peltekova et al. · 2013 · Human Genomics